Skip to content

A Clinical Trial To Study The Effect Of Shwasa Kasa Dashemani Ghana Kashaya In Patients With Chronic Bronchitis.

A Prospective Clinical Study Of Shwasa Kasa Dashemani Ghana Kashaya In Kaphaja Kasa W.S.R To Chronic Bronchitis. - Nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/04/065179
Enrollment
40
Registered
2024-04-04
Start date
Unknown
Completion date
Unknown
Last updated
2024-04-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J42- Unspecified chronic bronchitis

Interventions

None listed

Sponsors

NIL
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Lakshanas of Kaphaja kasa Diagnostic criteria of Chronic bronchitis

Exclusion criteria

Exclusion criteria: COVID 19 patients Active or untreated TB patients Patients with positive HIV , Hepatitis C and B. Psychiatric patients. Chronic Asthma patients.

Design outcomes

Primary

MeasureTime frame
Changed in the signs and symptoms of Kaphaja kasa. Changes in BCS SCALE (Breathlessness, Cough , Sputum) Changes in St.George Respiratory Questionnaire (SGRQ) score.Timepoint: 14 DAYS

Secondary

MeasureTime frame
Objective Peak flow metry testing. Timepoint: 2 weeks

Countries

India

Contacts

Public ContactDr Parveen Nadaf

Rajiv Gandhi University Of Health Sciences,Bengaluru

anisaralaya@gmail.com9986102083

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026